@FiercePharma: Top-read FP news yesterday: Sex, bribes and videotape: Clandestine video of GSK exec adds to China scandal. Report | Follow @FiercePharma
@TracyStaton: Here's @JohnCFierce's take on the Vertex VX-809/Kalydeco PhIII, including interview with CEO Jeff Leiden. Story | Follow @TracyStaton
@EricPFierce: ICYMI: FDA approves Ranbaxy's generic Diovan at Indian drugmaker's Ohm plant in New Jersey. Story | Follow @EricPFierce
@CarlyHFierce: Prevnar use in seniors is cost-effective now, CDC says. But will it last? FierceVaccines story | Follow @CarlyHFierce
> Vertex Pharmaceuticals ($VRTX) asked the FDA to expand use of its cystic fibrosis drug Kalydeco, to patients with a common mutation related to the disease. Release
> Bristol-Myers Squibb ($BMY) recalled 6 lots of injectable Coumadin after finding particulate matter in a small number of unreleased samples. Report
> Federal prosecutors urged a New York judge not to dismiss False Claims Act complaints against Novartis in a case involving alleged kickbacks to pharmacies. Report (reg. req.)
> Pfizer ($PFE) persuaded a Pennsylvania federal judge to exclude an expert witness in litigation over its antidepressant Zoloft and its potential inks to birth defects. Report
> Médecins Sans Frontiéres won approval from South African officials to import a cheap generic version of the anti-tuberculosis drug linezolid to allow it to treat more patients. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: Neuro-stimulator startup electroCore secures Series A expansion to $50M. Article | Follow @FierceMedDev
@StacyALawrence: Study: One-third of knee replacements are inappropriate. More | Follow @StacyALawrence
@VarunSaxena2: ICYMI yesterday: Stryker to buy Small Bone Innovations for up to $375M. Story | Follow @VarunSaxena2
@MichaelGFierce: Nanoparticles designed to prevent cancer, aid bones. More | Follow @MichaelGFierce
@EmilyWFierce: GPS tracking devices used to prevent injuries in U.S. Men's National Soccer Team players. Bloomberg story | Follow @EmilyWFierce
> Report: $2.3B in digital health venture financing in the first half. Item
> FDA clears 3D virtual reality device for surgical procedures. News
> In obesity device race, ReShape lines up with FDA. More
Biotech News
@FierceBiotech: $ABBV's gaze puts the brakes on $SHPG's plans for major M&A. ICYMI yesterday | Follow @FierceBiotech
@JohnCFierce: Biotech IPO scorecard: Hits, runs and errors mount in 9th inning frenzy (it's getting crazy out there). Report | Follow @JohnCFierce
@DamianFierce: A truly disruptive, outcomes-driven look at biotech's new nonsense. Xconomy piece | Follow @DamianFierce
@EmilyMFierce: ICYMI: Experimental heart disease vaccine lowers plaque in mice arteries. FierceBiotech Research article | Follow @EmilyMFierce
> Agenus spikes on positive data for its brain cancer vaccine. Story
> Sanofi bumps stake in Regeneron to 22.5%. Item
> Paratek absorbs the troubled Transcept in a reverse merger. Article
> Angling for early OK, Amgen wins 'breakthrough' title for leukemia drug. News
> Bluebird bio snares gene-editing tech in $156M buyout deal. Report
Biotech Research News
> New antibiotic may combat drug-resistant tuberculosis. Story
> Enzyme inhibitor could curb post-stroke injury. More
> Alzheimer's compound targets abnormal blood clots in brain. Story
> Experimental heart disease vaccine lowers arterial plaque in mice. Article
> Pfizer to partner with South African university on preclinical research. Item
Pharma Manufacturing News
> Teva growth hormone for children recalled after oil leaks into product. News
> Manufacturing questions lead to another CRL for Allergan migraine drug. Report
> Janssen will stop making antibiotic Levaquin. Item
> India's IPA hires consulting firm to help it overcome bad publicity. News
> Cipla buys capacity in Yemen with deal to control company there. Article
> FDA OKs Ranbaxy New Jersey plant to make generic Diovan. Story
And Finally... Stress is literally a killer in China, where about 600,000 people--including those in their twenties--die each year from working too hard. Report